|
|
 |
| found 79 articles for 0.000 sec |
  |
Group: alt.pl.fajka · Group Profile · Search for tabak in alt.pl.fajka
Author: Rotm
Date: Sep 3, 2008 04:43
... nie zrażać' :-)) m. inn. dlatego, kuńsekwentnie odmawiam Kol. M-kwadrat wpisów w Bazę... sugeruję: http://www.tobaccoreviews.com (ang.) http://www.daft.de/pmwiki.php/Tabak/Tabak (niem.) lecz: są tytonie OBIEKTYWNIE kiepskie [...] Czy Larsen jest obiektywnie kiepski? są gorsze, znacznie gorsze :-) obiektywnie kiepski pewnikiem uwzględniając kontekst i tło, oraz ponure ...
|
| Show full article (1.53Kb) · Show article thread |
Group: alt.flame.psychiatry · Group Profile · Search for tabak in alt.flame.psychiatry
Author: Thetaworks
Date: Sep 1, 2008 17:18
... FDA’s request for further review. “From an investor point of view, this ongoing problem with Zyprexa is going to make people nervous until there’s a resolution,” said Les Funtleyder, an analyst at Miller Tabak & Co. in New York. “The thing is, we don’t know when there will ever be resolution. It just keeps going on and on.” Zyprexa has been approved in more than 80 countries and has ...
|
| Show full article (7.01Kb) |
|
|
Group: alt.flame.psychiatry · Group Profile · Search for tabak in alt.flame.psychiatry
Author: Thetaworks
Date: Aug 30, 2008 10:14
... FDA’s request for further review. “From an investor point of view, this ongoing problem with Zyprexa is going to make people nervous until there’s a resolution,” said Les Funtleyder, an analyst at Miller Tabak & Co. in New York. “The thing is, we don’t know when there will ever be resolution. It just keeps going on and on.” Zyprexa has been approved in more than 80 countries and has ...
|
| Show full article (7.01Kb) |
Group: alt.flame.psychiatry · Group Profile · Search for tabak in alt.flame.psychiatry
Author: Theta Works
Date: Aug 24, 2008 10:58
... FDA’s request for further review. “From an investor point of view, this ongoing problem with Zyprexa is going to make people nervous until there’s a resolution,” said Les Funtleyder, an analyst at Miller Tabak & Co. in New York. “The thing is, we don’t know when there will ever be resolution. It just keeps going on and on.” Zyprexa has been approved in more than 80 countries and has ...
|
| Show full article (7.01Kb) |
Group: alt.flame.psychiatry · Group Profile · Search for tabak in alt.flame.psychiatry
Author: Theta Works
Date: Aug 20, 2008 15:37
... FDA’s request for further review. “From an investor point of view, this ongoing problem with Zyprexa is going to make people nervous until there’s a resolution,” said Les Funtleyder, an analyst at Miller Tabak & Co. in New York. “The thing is, we don’t know when there will ever be resolution. It just keeps going on and on.” Zyprexa has been approved in more than 80 countries and has ...
|
| Show full article (7.01Kb) |
Group: alt.flame.psychiatry · Group Profile · Search for tabak in alt.flame.psychiatry
Author: Theta Works
Date: Aug 17, 2008 10:06
... FDA’s request for further review. “From an investor point of view, this ongoing problem with Zyprexa is going to make people nervous until there’s a resolution,” said Les Funtleyder, an analyst at Miller Tabak & Co. in New York. “The thing is, we don’t know when there will ever be resolution. It just keeps going on and on.” Zyprexa has been approved in more than 80 countries and has ...
|
| Show full article (7.01Kb) |
|
 |
|
1 ·
2 ·
3 ·
4 ·
5 ·
6 ·
7 ·
8 ·
next |
|
|